In contrast, PD-L1 expression of CPS≥10 was not associated with BMI (p=0.131), sex (p=0.663), diabetes (p=0.652), tumor location (p=0.083), histology (p=0.093), grade (p=0.138), tumor depth (p=0.260), lymph node stage (p=0.694), metastasis stage (p=0.188), S-100 (p=0.888), D-240 (p=0.071), or HER-2 status (p=0.411). Here, ERBB2 is linked to neoplasm.